Casdin Capital, LLC Sangamo Therapeutics, Inc Transaction History

Casdin Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $3.28 Million - $6.21 Million	1,000,000 New	1,000,000 $4.14 Million
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $4.96 Million - $6.61 Million	-550,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $5.77 Million - $9.04 Million	-530,000 Reduced 49.07%	550,000 $6.89 Million
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $3.52 Million - $4.68 Million	-375,000 Reduced 25.77%	1,080,000 $10.2 Million
Q3 2019 Nov 12, 2019	SELL	$9.05 - $12.22 $13.8 Million - $18.7 Million	-1,530,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $13.2 Million - $17.8 Million	1,455,000 New	1,455,000 $16.5 Billion
Q2 2019 Aug 13, 2019	BUY	$8.75 - $13.03 $3.94 Million - $5.86 Million	450,000 Added 41.67%	1,530,000 $0
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $8.75 Million - $15.3 Million	-920,000 Reduced 46.0%	1,080,000 $12.4 Million
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $7.83 Million - $11.4 Million	600,000 Added 42.86%	2,000,000 $33.9 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $11.8 Million - $21 Million	1,400,000	1,400,000 $21 Million

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.